Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $97.0100 (0.31%) ($96.6420 - $97.4000) on Wed. Jul. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 48 | Latest Price | $97.0100(0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(50%) SPLV(38%) VYM(36%) DIA(34%) XLP(34%) | Factors Impacting ABBV price | ABBV will decline at least -0.785% in a week (0% probabilities). VIXM(-24%) UUP(-9%) VXX(-6%) TLT(-3%) XLC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | -0 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $98.42 | 5 Day Moving Average | $97.2(-0.2%) | 10 Day Moving Average | $98.07(-1.08%) | 20 Day Moving Average | $98.42(-1.43%) | To recent high | -3.8% | To recent low | 18.5% | Market Cap | $171.153b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |